Answers are grounded in this paper and cite their sources.
Combination vaccine elicits robust immune response in mice, indicating adaptability for future variants.
The rapid and ongoing emergence of SARS-CoV-2 variants has progressively reduced the protection offered by current vaccines, underscoring the urgent need for novel vaccine strategies. In this study, we designed a two-component vaccine in which one component is an adenoviral vector encoding the Omicron XBB.1.5 spike protein (Ad5 XBB.1.5 ), and the other component is a self-assembling trimeric receptor-binding domain protein (RBD XBB.1.5 -HR or RBD JN.1 -HR). This platform integrates the complementary advantages of subunit protein and adenoviral vector vaccines, elicits robust humoral and cellular immunity in mice after intramuscular administration. Durable IgG responses induced by this two-component vaccine were maintained for over six months post-immunization in mice, attributed to their ability to generate memory B cells and long-lived plasma cells responses. Furthermore, in a heterologous booster setting following mRNA (mRNA BA.4 and mRNA XBB.1.5 ) priming, the two-component vaccine can be severed as a boost shot to rescue the neutralization against emerging variants, such as JN.1. These findings indicate that the two-component vaccine system can act effectively on its own and also serve as a heterologous booster that enhances protection against antigenically evolved variants. Furthermore, the modularity of this platform suggests broad applicability for rapid adaptation to future SARS-CoV-2 strains and for vaccine development against other fast-evolving respiratory viruses. Collectively, this study provides a generalizable framework for next-generation COVID-19 vaccine design and supports the translational relevance of two-component vaccines in the context of continual viral diversification.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: